Dilated cardiomyopathy (DCM) frequently affects relatively young, economically, and
socially active adults, and is an important cause of heart failure and transplantation. DCM is …

Dilated cardiomyopathy (DCM) is an umbrella term entailing a wide variety of genetic and
non-genetic etiologies, leading to left ventricular systolic dysfunction and dilatation, not …

Abstract Purpose of Review This review aims to summarize the current knowledge on the
genetic background of dilated cardiomyopathy (DCM), with particular attention to the …

Heart failure is a global health burden responsible for high morbidity and mortality with a
prevalence of greater than 60 million individuals worldwide. One of the major causes of …

Cardiomyopathies (CMPs) are “myocardial diseases characterized by structurally and
functionally abnormal heart muscle and absence of other diseases sufficient to cause the …

Advances in human genome sequencing have re-invigorated genetics studies of dilated
cardiomyopathy (DCM), facilitating genetic testing and clinical applications. With a range of …

Dilated cardiomyopathy (DCM) is defined as dilation and/or reduced function of one or both
ventricles and remains a common disease worldwide. An estimated 40% of cases of familial …

Abstract Purpose of Review Dilated cardiomyopathy (DCM) is characterized by left
ventricular dilation and systolic function and is the most common among all …

Dilated cardiomyopathy (DCM) is a major cause of sudden cardiac death and heart failure,
and it is characterized by genetic and clinical heterogeneity, even for some patients with a …

The genetic evaluation of dilated cardiomyopathy (DCM) has been challenging, owing in
large part to marked genetic heterogeneity. However, lower costs from next-generation …